Sphingosine 1-phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons

Journal of Cellular and Molecular Medicine

Volumn 20, Issue 6, 2016, Pages 1170-1181

  Frej, Cecilia ^a   Linder, Adam ^b   Happonen, Kaisa E ^a   Taylor, Fletcher B ^c   Lupu, Florea ^c   Dahlbäck, Björn ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

SIRS; Apolipoproteins; HDL; Lipoproteins; Lysophospholipids

Indexed keywords

ALBUMIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN M; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; SPHINGOSINE 1 PHOSPHATE; APOLIPOPROTEIN; APOM PROTEIN, HUMAN; LIPOCALIN; LYSOPHOSPHOLIPID; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE;

ADULT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BABOON; CONTROLLED STUDY; DISEASE SEVERITY; ESCHERICHIA COLI INFECTION; GEL FILTRATION CHROMATOGRAPHY; HISTOLOGY; HUMAN; LD50; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; RNA TRANSCRIPTION; SEPSIS; THROMBOCYTE COUNT; ANALOGS AND DERIVATIVES; ANIMAL; BACTERIAL COUNT; BLOOD; CASE CONTROL STUDY; ERYTHROCYTE; ESCHERICHIA COLI; GENETIC TRANSCRIPTION; GENETICS; KIDNEY; LEUKOCYTE; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; SIZE EXCLUSION CHROMATOGRAPHY; THROMBOCYTE;

ANIMALS; APOLIPOPROTEINS; BLOOD PLATELETS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, GEL; COLONY COUNT, MICROBIAL; ERYTHROCYTES; ESCHERICHIA COLI; HUMANS; KIDNEY; LEUKOCYTES; LIPOCALINS; LYSOPHOSPHOLIPIDS; PAPIO; RNA, MESSENGER; SEPSIS; SPHINGOSINE; TRANSCRIPTION, GENETIC;

EID: 84961262369     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12831     Document Type: Article

References (58)

1. Cohen J, Vincent JL, Adhikari NK, et al. Sepsis: a roadmap for future research. Lancet Infect Dis. 2015; 15: 581-614.
2. Barlage S, Gnewuch C, Liebisch G, et al. Changes in HDL-associated apolipoproteins relate to mortality in human sepsis and correlate to monocyte and platelet activation. Intensive Care Med. 2009; 35: 1877-85.
3. Tsai MH, Peng YS, Chen YC, et al. Low serum concentration of apolipoprotein A-I is an indicator of poor prognosis in cirrhotic patients with severe sepsis. J Hepatol. 2009; 50: 906-15.
4. Baker PW, Rye KA, Gamble JR, et al. Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells. J Lipid Res. 1999; 40: 345-53.
5. Cockerill GW, Rye KA, Gamble JR, et al. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol. 1995; 15: 1987-94.
6. Wurfel MM, Kunitake ST, Lichenstein H, et al. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp Med. 1994; 180: 1025-35.
7. Ulevitch RJ, Johnston AR, Weinstein DB. New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides. J Clin Invest. 1979; 64: 1516-24.
8. Levine DM, Parker TS, Donnelly TM, et al. In vivo protection against endotoxin by plasma high density lipoprotein. Proc Natl Acad Sci USA. 1993; 90: 12040-4.
9. Wilkerson BA, Grass GD, Wing SB, et al. Sphingosine 1-phosphate (S1P) carrier-dependent regulation of endothelial barrier: high density lipoprotein (HDL)-S1P prolongs endothelial barrier enhancement as compared with albumin-S1P via effects on levels, trafficking, and signaling of S1P1. J Biol Chem. 2012; 287: 44645-53.
10. Argraves KM, Gazzolo PJ, Groh EM, et al. High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function. J Biol Chem. 2008; 283: 25074-81.
11. Frej C, Andersson A, Larsson B, et al. Quantification of sphingosine 1-phosphate by validated LC-MS/MS method revealing strong correlation with apolipoprotein M in plasma but not in serum due to platelet activation during blood coagulation. Anal Bioanal Chem. 2015; 407: 8533-42.
12. Xu N, Dahlback B. A novel human apolipoprotein (apoM). J Biol Chem. 1999; 274: 31286-90.
13. Christoffersen C, Ahnstrom J, Axler O, et al. The signal peptide anchors apolipoprotein M in plasma lipoproteins and prevents rapid clearance of apolipoprotein M from plasma. J Biol Chem. 2008; 283: 18765-72.
14. Christoffersen C, Obinata H, Kumaraswamy SB, et al. Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. Proc Natl Acad Sci U S A. 2011; 108: 9613-8.
15. Ahnstrom J, Faber K, Axler O, et al. Hydrophobic ligand binding properties of the human lipocalin apolipoprotein M. J Lipid Res. 2007; 48: 1754-62.
16. Liu M, Seo J, Allegood J, et al. Hepatic apolipoprotein M (ApoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein. J Biol Chem. 2014; 289: 2801-14.
17. Kurano M, Tsukamoto K, Ohkawa R, et al. Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M. Atherosclerosis. 2013; 229: 102-9.
18. Obinata H, Hla T. Sphingosine 1-phosphate in coagulation and inflammation. Semin Immunopathol. 2012; 34: 73-91.
19. Liu H, Chakravarty D, Maceyka M, et al. Sphingosine kinases: a novel family of lipid kinases. Prog Nucleic Acid Res Mol Biol. 2002; 71: 493-511.
20. Ikeda M, Kihara A, Igarashi Y. Sphingosine-1-phosphate lyase SPL is an endoplasmic reticulum-resident, integral membrane protein with the pyridoxal 5'-phosphate binding domain exposed to the cytosol. Biochem Biophys Res Commun. 2004; 325: 338-43.
21. Le Stunff H, Galve-Roperh I, Peterson C, et al. Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis. J Cell Biol. 2002; 158: 1039-49.
22. Teijaro JR, Walsh KB, Cahalan S, et al. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell. 2011; 146: 980-91.
23. Olivera A, Mizugishi K, Tikhonova A, et al. The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. Immunity. 2007; 26: 287-97.
24. Garcia JG, Liu F, Verin AD, et al. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest. 2001; 108: 689-701.
25. Mandala S, Hajdu R, Bergstrom J, et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science. 2002; 296: 346-9.
26. Matloubian M, Lo CG, Cinamon G, et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature. 2004; 427: 355-60.
27. Kawa S, Kimura S, Hakomori S, et al. Inhibition of chemotactic motility and trans-endothelial migration of human neutrophils by sphingosine 1-phosphate. FEBS Lett. 1997; 420: 196-200.
28. Michels M, Japtok L, Alisjahbana B, et al. Decreased plasma levels of the endothelial protective sphingosine-1-phosphate are associated with dengue-induced plasma leakage. J Infect. 2015; 71: 480-7.
29. Camerer E, Regard JB, Cornelissen I, et al. Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J Clin Invest. 2009; 119: 1871-9.
30. Lundblad C, Axelberg H, Grande PO. Treatment with the sphingosine-1-phosphate analogue FTY 720 reduces loss of plasma volume during experimental sepsis in the rat. Acta Anaesthesiol Scand. 2013; 57: 713-8.
31. Kumaraswamy SB, Linder A, Akesson P, et al. Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes. Crit Care. 2012; 16: R60.
32. Feingold KR, Shigenaga JK, Chui LG, et al. Infection and inflammation decrease apolipoprotein M expression. Atherosclerosis. 2008; 199: 19-26.
33. Winkler MS, Nierhaus A, Holzmann M, et al. Decreased serum concentrations of sphingosine-1-phosphate in sepsis. Crit Care. 2015; 19: 372.
34. Linder A, Christensson B, Herwald H, et al. Heparin-binding protein: an early marker of circulatory failure in sepsis. Clin Infect Dis. 2009; 49: 1044-50.
35. Axler O, Ahnström J, Dahlbäck B. An ELISA for apolipoprotein M reveals a strong correlation to total cholesterol in human plasma. J Lipid Res. 2007; 48: 1772-80.
36. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25: 402-8.
37. Taylor FB Jr, Kinasewitz GT, Lupu F. Pathophysiology, staging and therapy of severe sepsis in baboon models. J Cell Mol Med. 2012; 16: 672-82.
38. Taylor FB Jr, Wada H, Kinasewitz G. Description of compensated and uncompensated disseminated intravascular coagulation (DIC) responses (non-overt and overt DIC) in baboon models of intravenous and intraperitoneal Escherichia coli sepsis and in the human model of endotoxemia: toward a better definition of DIC. Crit Care Med. 2000; 28: S12-9.
39. Barlage S, Frohlich D, Bottcher A, et al. ApoE-containing high density lipoproteins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response. J Lipid Res. 2001; 42: 281-90.
40. McGillicuddy FC, de la Llera Moya M, Hinkle CC, et al. Inflammation impairs reverse cholesterol transport in vivo. Circulation. 2009; 119: 1135-45.
41. Van Lenten BJ, Hama SY, de Beer FC, et al. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest. 1995; 96: 2758-67.
42. Pirillo A, Catapano AL, Norata GD. HDL in infectious diseases and sepsis. Handb Exp Pharmacol. 2015; 224: 483-508.
43. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988; 240: 622-30.
44. Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness. Br J Anaesth. 2000; 85: 599-610.
45. de Stoppelaar SF, van't Veer C, der van Poll T. The role of platelets in sepsis. Thromb Haemost. 2014; 112: 666-77.
46. Lang F, Qadri SM. Mechanisms and significance of eryptosis, the suicidal death of erythrocytes. Blood Purif. 2012; 33: 125-30.
47. Silasi-Mansat R, Zhu H, Popescu NI, et al. Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis. Blood. 2010; 116: 1002-10.
48. Gruen JR, Weissman SM. Evolving views of the major histocompatibility complex. Blood. 1997; 90: 4252-65.
49. Wolfrum C, Poy MN, Stoffel M. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat Med. 2005; 11: 418-22.
50. Galvani S, Sanson M, Blaho VA, et al. HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation. Sci Signal. 2015; 8: ra79. DOI: 10.1126/scisignal.aaa2581.
51. Xu N, Hurtig M, Zhang XY, et al. Transforming growth factor-beta down-regulates apolipoprotein M in HepG2 cells. Biochim Biophys Acta. 2004; 1683: 33-7.
52. Laun RA, Schroder O, Schoppnies M, et al. Transforming growth factor-beta1 and major trauma: time-dependent association with hepatic and renal insufficiency. Shock. 2003; 19: 16-23.
53. de Pablo R, Monserrat J, Reyes E, et al. Sepsis-induced acute respiratory distress syndrome with fatal outcome is associated to increased serum transforming growth factor beta-1 levels. Eur J Intern Med. 2012; 23: 358-62.
54. Faber K, Axler O, Dahlback B, et al. Characterization of apoM in normal and genetically modified mice. J Lipid Res. 2004; 45: 1272-8.
55. Trauner M, Arrese M, Lee H, et al. Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. J Clin Invest. 1998; 101: 2092-100.
56. Fu P, Wang AM, He LY, et al. Elevated serum ApoE levels are associated with bacterial infections in pediatric patients. J Microbiol Immunol Infect. 2014; 47: 122-9.
57. Li L, Thompson PA, Kitchens RL. Infection induces a positive acute phase apolipoprotein E response from a negative acute phase gene: role of hepatic LDL receptors. J Lipid Res. 2008; 49: 1782-93.
58. Kurano M, Tsukamoto K, Hara M, et al. LDL receptor and ApoE are involved in the clearance of ApoM-associated sphingosine 1-phosphate. J Biol Chem. 2015; 290: 2477-88.